We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Anti-Human GDNF pAb

Antibody Specific to GDNF for Investigating Neuronal Systems

  • Chicken IgY antibody generated using human recombinant GDNF
  • Cross-reactive between mammalian species; does not cross-react with TGFα, TGFβ1, NGF or BDNF at up to 10μg/ml
  • Antibody provided at 0.5mg/ml in 0.1M NaCl, 0.01M K2HPO4, 50μg/ml gentamicin

Size

Catalog number selected: G2791

$ 440.00 Your price: Log In

Anti-Human GDNF pAb
200μg
$ 440.00
Your price: Log In

Human glial cell-line-derived neurotrophic factor (GDNF), a 30kDa homodimer, has been shown to be a potent survival factor for a variety of neurons. The receptor complex for GDNF has been elucidated, though members of the multicomponent receptor family continue to grow. With applications in Western blotting, ELISA and immunostaining, the Anti-Human GDNF pAb is a useful tool to continue the investigation of GDNF's role in multiple facets of neurological systems.

Applications (suggested working concentration)

  • Western blotting (1μg/ml).
  • ELISA (1μg/ml).
  • Immunohistochemistry.

Specifications

What's in the box?

Item Part # Size

Anti-Human GDNF pAb

G279A 1 x 200μg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

Resources

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom